Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Awards granted on 8 March 2024 under the Smith & Nephew plc
Deferred Share Bonus Plan.
|
Date of Transaction
|
2024 - 03 - 08
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (s)
|
Volume(s)
|
Aggregated information
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
£10.875
|
72,005
|
N/A Single Transaction
|
Anne-Françoise
Nesmes
(Chief Executive Officer)
|
Director
|
£10.875
|
37,368
|
N/A Single Transaction
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Deferred Bonus Plan awards granted on 8 March 2024 under the Smith
& Nephew Global Share Plan 2020.
|
Date of Transaction
|
2024 - 03 - 08
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Helen Barraclough
(Group General Counsel and Company Secretary)
|
PDMR
|
£10.875
|
9,366
|
N/A Single Transaction
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
£10.875
|
9,849
|
N/A Single Transaction
|
Phil Cowdy
(Chief Corporate Development and Corporate Affairs
Officer)
|
PDMR
|
£10.875
|
10,093
|
N/A Single Transaction
|
Craig Gaffin
President, Global Orthopaedics
|
PDMR
|
£10.875
|
5,572
|
N/A Single Transaction
|
Rohit Kashyap
(President AWM and Global Commercial Operations)
|
PDMR
|
£10.875
|
11,031
|
N/A Single Transaction
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
£10.875
|
11,327
|
N/A Single Transaction
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
£10.875
|
14,129
|
N/A Single Transaction
|
Vasant Padmanabhan
(President Research & Development ENT)
|
PDMR
|
£10.875
|
14,214
|
N/A Single Transaction
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
£10.875
|
5,474
|
N/A Single Transaction
|
Scott Schaffner
(President Sports Medicine)
|
PDMR
|
£10.875
|
17,652
|
N/A Single Transaction
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Performance Share Awards granted at target on 8 March 2024 under
the Smith & Nephew Global Share Plan 2020.
|
Date of Transaction
|
2024 - 03 - 08
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Helen Barraclough
(Group General Counsel and Company Secretary)
|
PDMR
|
£10.875
|
35,803
|
N/A Single Transaction
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
£10.875
|
43,926
|
N/A Single Transaction
|
Phil Cowdy
(Chief Corporate Development and Corporate Affairs
Officer)
|
PDMR
|
£10.875
|
38,581
|
N/A Single Transaction
|
Craig Gaffin
President, Global Orthopaedics
|
PDMR
|
£10.875
|
70,920
|
N/A Single Transaction
|
Rohit Kashyap
(President AWM and Global Commercial Operations)
|
PDMR
|
£10.875
|
98,357
|
N/A Single Transaction
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
£10.875
|
45,088
|
N/A Single Transaction
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
£10.875
|
56,239
|
N/A Single Transaction
|
Deepak Nath
(Chief Executive Officer)
|
PDMR
|
£10.875
|
151,365
|
N/A Single Transaction
|
Vasant Padmanabhan
(President Research & Development ENT)
|
PDMR
|
£10.875
|
56,577
|
N/A Single Transaction
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
£10.875
|
10,429
|
N/A Single Transaction
|
Scott Schaffner
(Global President Sports Medicine)
|
PDMR
|
£10.875
|
85,666
|
N/A Single Transaction
|
|
Award
vesting as % of salary at date of grant
|
|
|
Sector
based peer group
|
FTSE100
peer group
|
Below
the index
|
Nil
|
Nil
|
Equaling
the index
|
8.6%
|
8.6%
|
8%
above the index
|
34.4%
|
34.4%
|
Return
on Invested Capital
Year
ended 31 December 2026
|
Award
vesting as a % of salary
|
Below
8.5%
|
Nil
|
8.5%
|
17.2%
|
9.0%
|
34.4%
|
10.5%
|
68.8%
|
Revenue
Growth
Three
years ended 31 December 2026
|
Award
vesting as a % of salary
|
Below
Threshold
|
Nil
|
Threshold
(-8% of target)
|
17.2%
|
Target
- set by reference to our expectations
|
34.4%
|
Maximum
or above (+8% of target)
|
68.8%
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
March 11, 2024
|
By:
|
/s/
Helen Barraclough
|
|
|
Helen
Barraclough
|
|
|
Company
Secretary
|